Why investors prefer Delaware C-Corps (and what QSBS has to do with it)
When a US investor asks "do you have a US entity?", this is everything hiding behind the question.
The short answer
US investors prefer Delaware C-Corps because the entire venture machine is built for them: standardised documents, predictable Delaware law, and native support for preferred stock and option pools — plus QSBS, a US tax provision that can make a qualifying investor's exit gains entirely free of federal capital-gains tax. Only C-Corp stock qualifies.
Pitch a US fund with an Indian Pvt Ltd on your deck and watch what happens. The first question isn’t about your product, your traction, or your team. It’s “do you have a US entity?” Many founders begin the whole cross-border journey because an investor asked exactly that.
It’s tempting to read this as American parochialism. It isn’t. There are three boring, rational reasons — and one tax reason that is anything but boring. Let’s take them in order.
What happens when a US fund looks at an Indian company?
Friction, everywhere. To invest in an Indian Pvt Ltd, a US fund needs Indian counsel, has to price the round inside FEMA’s valuation rules, files with a regulator it’s never met, and accepts that its exit — the only moment a fund actually earns anything — will be governed by Indian law and Indian timelines. Its LPs signed up for none of this.
Now compare the alternative. To invest in a Delaware C-Corp, the same fund opens the standard document set, changes the names and numbers, and wires the money. The US venture industry has spent thirty years standardising itself — SAFEs, board consents, the whole choreography — and every one of those documents assumes one thing: a Delaware corporation. Investing in one is a solved problem. Investing in anything else is a project.
Why Delaware, specifically?
Not tax — Delaware isn’t a tax haven for startups, and you’ll pay its franchise tax for the privilege (more on that in the capitalisation guide). The real answer is predictability. Delaware has the deepest corporate case law in the world and a specialist court that hears nothing but business disputes, which means that for almost any governance question that can arise between founders and investors, everyone’s lawyers already know how it ends. Funds price uncertainty. Delaware has the least of it.
And there’s a network effect that does the rest: because everyone incorporates in Delaware, every investor, lawyer, and acquirer is fluent in it — which makes the next company incorporate in Delaware too. Nobody ever got fired for choosing it.
Why a C-Corp and not an LLC?
Because the machinery VCs run on exists natively in a C-Corp and only awkwardly anywhere else. Preferred stock with liquidation preferences — the instrument every priced round is built on — is a C-Corp construct. Clean option pools for employees: C-Corp. SAFEs that stack quietly until they convert: written for C-Corps.
The LLC’s famous advantage — pass-through taxation — is precisely what funds don’t want. A pass-through entity pushes its tax consequences up to its owners, and a venture fund’s owners include pension funds, endowments, and foreign investors who cannot tolerate US tax filings landing on them because a portfolio company had a good year. A C-Corp pays its own taxes and bothers nobody upstream. For a fund, that containment is a feature worth insisting on.
What is QSBS, in plain English?
Now the reason with numbers attached. QSBS — Qualified Small Business Stock, Section 1202 of the US tax code — is a provision that lets investors in qualifying startups exclude some or all of their gains from federal capital-gains tax when they exit. Not defer. Exclude.
The mechanics, in one breath: if the company was a US C-Corporation with gross assets under $75 million when your stock was issued, you got the stock at original issuance, and the business is a qualifying one, then — for stock issued after July 4, 2025 — holding it three years excludes 50% of your gain from federal tax, four years excludes 75%, and five years excludes 100%, up to a cap of $15 million or ten times what you paid, whichever is greater.
Run the numbers on a real case. An angel puts $500k into your seed round. Seven years later their stake sells for $10 million. Federal capital-gains tax on the $9.5 million gain: zero. That is not a loophole; it’s the explicit design — the US wants early-stage risk capital and pays for it. Once you know this provision exists, US angels steering you toward a Delaware C-Corp stops looking like pedantry and starts looking like what it is: they’re protecting a tax-free exit. Which, note, is alignment — it costs you nothing, and it makes your cap table more attractive to every US investor who understands it.
the actual rule: Section 1202 / QSBS
And what if that same $500k went into an India-HQ company instead?
Run the counterfactual, because this is where the preference stops being abstract. Same angel, same $500k, but into your Indian Pvt Ltd’s seed round instead. Seven years later, same great outcome: their stake sells for $10 million.
First thing: no QSBS. Section 1202 attaches only to US C-Corporation stock — an Indian company can’t qualify, full stop. So the exit is taxed like any other exit, twice over. India taxes it first: gains on unlisted shares held over 24 months are long-term, at a flat 12.5% with no indexation — call it roughly 13–15% once surcharge and cess stack on — and because the seller is a non-resident, the buyer withholds Indian tax at source before the money even moves. Then the US taxes the same gain again, at long-term capital-gains rates plus the investment-income surtax, giving credit for what India already took. Net-net, a top-bracket US investor keeps roughly three-quarters of the gain — versus all of it under QSBS.
So the honest scoreboard on a $9.5 million gain: Delaware C-Corp with QSBS — federal tax zero. India-HQ — something like a quarter of the gain across two tax systems, with withholding paperwork in India and a credit claim in the US. Your investor’s preference isn’t ideology; it’s arithmetic.
Two things to say in India’s defence, because folklore runs ahead of the facts. The infamous “angel tax” on premium-priced startup rounds was abolished — that fear is dead. And gains for foreign investors in unlisted Indian shares are computed with a foreign-exchange adjustment, so they aren’t taxed on rupee depreciation masquerading as profit. India has genuinely gotten friendlier. But friendlier isn’t zero — and none of it removes the mechanical friction (FEMA pricing on entry and exit, transfer filings, withholding) that makes the Indian cheque a project where the Delaware cheque is a form.
One symmetry to hold onto, because it’s the whole thesis of the structure chooser: an Indian resident investor exiting that same Indian company pays just the domestic 12.5% — one tax system, no withholding drama, home-turf paperwork. Which is exactly why Indian investors are perfectly content with an India-parent structure, and US investors aren’t. Each side prefers the structure their own tax system rewards. Who funds you decides what sits on top.
The fine print Indian founders should actually care about
Building fintech? The qualifying-business list excludes financial services — lending, broking, insurance. Your investors may not get QSBS on you at all, which is worth knowing before someone dangles it in a negotiation. (Financial services keeps appearing as a special case across this whole subject — it gets flagged in the LLP route guide too.)
Original issuance only. QSBS attaches to stock bought from the company, not from another shareholder — secondaries don’t qualify. One more reason early investors want in early and directly.
It’s a benefit for US taxpayers. QSBS reduces US federal tax. It does nothing about your Indian taxes, and whether any QSBS benefit can reach an Indian founder holding through an LLP is a genuinely unsettled question involving how US tax law looks through foreign entities — one for a US tax attorney, not a blog post, and deliberately not answered here.
The honest summary for you as a founder: QSBS is mostly your investors’ prize, not yours. But their prize shapes their preferences, and their preferences shape your structure. You don’t need to benefit from Section 1202 to be governed by it.
! CAREFUL
This is general information about why the preference exists — not tax advice, and QSBS eligibility is decided on facts across the entire holding period, not at incorporation. The US rules changed materially in 2025, and the Indian capital-gains regime changed materially in 2024 and was re-housed in the Income-tax Act, 2025 — the figures above are the current parameters as of mid-2026. Surcharge and withholding vary by investor and treaty position. Anything that matters should be confirmed with a US tax adviser and an Indian CA at the time it matters.
So what does this mean for you? You’re not choosing Delaware for yourself. You’re choosing the container your future investors’ machine is built to plug into — their documents, their law, their preferred stock, and their tax-free exit. If those investors are American, the container is a Delaware C-Corp, and the only real question left is how an Indian resident founder is allowed to hold one. That question has a whole guide: the LLP route. And if you’re still deciding whether your investors will be American at all, start one step earlier, with the structure chooser.
Not sure whether the C-Corp track is even your track? That's the most common starting point there is. Book a structuring clarity call.
Questions people ask
Why do US VCs only invest in Delaware C-Corps?
What is QSBS in simple terms?
Does QSBS benefit Indian founders directly?
Can an LLC qualify for QSBS?
What changed in QSBS in 2025?
How is a US investor taxed on an exit from an Indian company?
Related guides
The IP-before-incorporation question -- coming soon
Returning NRIs / dismantling the LLP later -- coming soon
LRS route for non-controlling investment -- coming soon